Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
acquired immunodeficiency syndrome dementia complex
acquired immunodeficiency syndrome, older adults
activated protein C resistance
aducanumab
advance directives
advances in neurology
adverse drug reaction
aerobic exercise
age associated memory impairment
aggression
agitation
algorithm
aluminum
Alzheimer's disease
Alzheimer's disease, conjugal
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early onset
Alzheimer's disease, early symptoms
Alzheimer's disease, familial
Alzheimer's disease, familial, late onset
Alzheimer's disease, incidence
Alzheimer's disease, misdiagnosis
Alzheimer's disease, pathogenesis
Alzheimer's disease, patient awareness of
Alzheimer's disease, preclinical
Alzheimer's disease, rapidly progressive
Alzheimer's disease, rate of clinical decline
Alzheimer's disease, risk factors in
Alzheimer's disease, treating associated medical problems in
Alzheimer's disease, treatment of
amnesia
amyloid
amyloid beta protein
amyloid beta protein antibodies
amyloid deposition
amyloid imaging
amyloid plaques
amyloidosis
amyloid-related imaging abnormalities
amyotrophic lateral sclerosis
anatomy of
angiotensin II receptor blocker
anti-amyloid therapy
anticoagulant, treatment
anticonvulsants
antihypertensive
antiphospholipid antibodies
antithrombin III deficiency
anxiety
apolipoprotein E
apoliprotein E, plasma level
APP
APP gene
asymptomatic
atrial fibrillation
atypical
automobile accidents
autonomic dysfunction
behavioral disorder
benzodiazepine
biologic markers
blacks
blood pressure
blood transfusion
bone density
carcinoma
caregiver
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, venography
cerebral edema
cerebral edema, vasogenic
cerebral infarction
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, familial occurrence
cerebrovascular accident, infancy and childhood
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, risk factors in
children
chromosomal abnormality
chromosome 12
cigarette smoking
clinical trials
cognition
comorbidities
complications
confusion
contraindications
controversies in neurology
cost
coumarin
craniectomy, decompressive
D-dimer
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, clinical diagnosis
dementia, diagnostic evaluation of
dementia, differential diagnosis of
dementia, driving with
dementia, early detection
dementia, familial
dementia, incidence
dementia, prevalence of
dementia, prevention of
dementia, rapidly progressive
dementia, screening for
dementia, treatment of
depression
diabetes mellitus
diagnostic criteria
disease modifying agents
dizziness
donanemab
donepezil
driving
drug abuse
dural sinus thrombosis
educational status
efficacy
electromagnetic fields
endovascular therapy
epidemiology of neurology
ethics in neurology
evidence-based research
exercise
Factor V Leiden
familial
fibrinolytic agents
fibrinolytic agents, intra-venous local infusion
fibrinolytic agents, utilization
fracture, long bone
gadolinium
gantenerumab
gender
gene
genetic counselling
genetic linkage
genetic neurologic disorders
genetic screening
genetic testing
glaucoma
haloperidol
head injury
headache
hemiparesis
hemosiderosis of CNS, superficial
heralding manifestation
herpes simplex virus
hip fracture
hippocampal atrophy
hippocampus
Hispanics
homocysteine, serum
homosexual
hormone replacement
hormone therapy
human immunodeficiency virus type 1
hydrocephalus
hypercholesterolemia
hyperhomocysteinemia
hyperinsulinism
hypertension
hypoxia
iatrogenic neurologic disorders
incidence
intellectual deficit
intellectual deterioration
intracerebral hemorrhage
intracranial pressure, increased
inverse association
Jakob-Creutzfeldt disease
lecanemab
leisure activity
level of consciousness, decreased
lifestyle
limbic system
limbic-predominant age-related TDP-43 encephalopathy
lipid lowering agent
managed care
marital status
medical-legal aspects of neurology
memory
memory, defect of recent
memory, evaluation of
memory, impairment of
memory, impairment of, isolated
memory, impairment of, subjective
meningitis
menopause
mental activity
mental status, abnormal
mesial temporal lobe
microhemorrhage, intracerebral
middle cerebral artery territory infarction
middle cerebral artery, occlusion of
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
mimics
Mini Mental Status Examination
misdiagnosis
molecular genetics
mongolism
monoclonal antibodies
mortality
motor neuron disease
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, functional
MRI, venography
multiple sclerosis
myoclonus
negative
nerve growth factor
neurofibrillary degeneration
neuroleptic
neuroleptic, atypical
neurologic complications of, systemic disease
neurologic consultation
neurologic disease, diagnoses of
neurologic evaluation
neurologic examination, focal
neurologic signs
neurologic symptoms
neuropathology
neuropathy
neuroprotective agents
nicotine
nonsteroidal anti-inflammatory drug
normal
occupational neurologic disorders
old age, driving and
old age, neurology of
oral contraceptives
oral contraceptives, cerbrovascular disease and
oral contraceptives, neurologic complications with
osteoporosis
Parkinson disease
Parkinson disease, etiology of
patient information and support
pitfalls
Pittsburgh Compound B
placebo
polysomnogram
practice guidelines
preclinical
pregnancy, neurologic complications in
premarin
presenilin-1 gene
presenilin-2 gene
prethrombotic state
prevention of neurologic disorders
progesterone
prognosis
protein C deficiency
protein S deficiency
proteinopathy
psychological testing
psychotic behavior
remternetug
research
review article
rhinorrhea, CSF
risk factors
risk factors, modification
risk-benefit assessment
risperidone
rosacea
safety
screening
seizure
seizure, elderly
seizure, focal
seizure, risk factors for
selective serotonin reuptake inhibitors
senile plaques
shared decision making
sildenafil
skin, lesions in neurologic disorders
sleep
sleep pathology and physiology
smell
Smell Identification Test
sodium-glucoe cotransporter-2 inhibitors
straight sinus
stress, emotional
superior sagittal sinus thrombosis
tau protein
TDP-43 proteinopathy
temporal lobe, atrophy
tissue plasminogen activator, intravenous
TRAILBLAZER-ALZ trial
treatment of neurologic disorder
TREM2 variants
water, drinking
weight loss
white matter disease
whites
workup
Showing articles 1650 to 1700 of 7385 << Previous Next >>

Chickenpox and Stroke in Childhood
Stroke 32:1257-1262, Askalan,R.,et al, 2001

Subclinical Dopaminergic Dysfunction in Asymptomatic Parkinson's Disease Patients' Relatives with a Decreased Sense of Smell
Ann Neurol 50:34-41, Berendse,H.W.,et al, 2001

Prevalence and Predicators of Early Seizure and Status Epilepticus After First Stroke
Neurol 57:200-206, Labovitz,D.L.,et al, 2001

Epidemic West Nile Encephalitis, New York, 1999: Results of a Household-based Seroepidemiological Survey
Lancet 358:261-264,254, Mostashari,F.,et al, 2001

Clinical Study of 222 Patients with Pure Motor Stroke
JNNP 71:239-242, Arboix,A.,et al, 2001

Stroke After Coronary Artery Bypass
Stroke 32:1508-1513, Stamou,S.C.,et al, 2001

Dietary Potassium Intake and Risk of Stroke in US Men and Women
Stroke 32:1473-1480, Bazzano,L.A.,et al, 2001

Vitamin D Deficiency and Risk of Hip Fractures Among Disabled Elderly Stroke Patients
Stroke 32:1673-1677, Sato,Y.,et al, 2001

Galantamine (Reminyl) for Alzheimer's Disease
Medical Letter 43:53-54, , 2001

Welding-Related Parkinsonism
Neurol 56:8-13,4, Racette,B.A.,et al, 2001

Cellular-Telephone Use and Brain Tumors
NEJM 344:79-86,133, Inskip,P.D.,et al, 2001

Intake of Fish and Omega-3 Fatty Acids and Risk of Stroke in Women
JAMA 285:304-312, Iso,H.,et al, 2001

Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001

Risk Factors for Cerebral edema in Children With Diabetic Ketoacidosis
NEJM 344:264-269,302, Glaser,N.,et al, 2001

Use of Aspirin, Epistaxis, and Untreated Hypertension as Risk Factors for Primary Intracerebral Hemorrhage in Middle-Aged and Elderly People
Stroke 32:399-404, Saloheimo,P.,et al, 2001

Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001

Longitudinal Assessment of Neurocognitive Function After Coronary-Artery Bypass Surgery
NEJM 344:395-402,451, Newman,M.F.,et al, 2001

Factors Affecting Formation and Growth of Intracranial Aneurysms
Stroke 32:485-491, Juvela,S.,et al, 2001

Low Back Pain
NEJM 344:363-370, Deyo,R.A. &Weinstein,J.N., 2001

Frequency and Predictors of Stroke Death in 5,888 Participants in the Cardiovascular Health Study
Neurol 56:368-375, Longstreth,W.T.,et al, 2001

Embolism in Acute Middle Cerebral Artery Stenosis
Neurol 56:497-501, Segura,T.,et al, 2001

Assessment of Aspiration Risk in Stroke Patients with Quantification of Voluntary Cough
Neurol 56:502-506, Hammond,C.A.S.,et al, 2001

Incidence and Risk Factors in Sudden Unexpected Death in Epilepsy
Neurol 56:519-525, Walczak,T.S.,et al, 2001

Assessing the Risk of Early Multiple Sclerosis in Patients with Clinically Isolated Syndromes: the Role of a Follow Up MRI
JNNP 70:390-393, Brex,P.A.,et al, 2001

Onset of Multiple Sclerosis Associated With Anti-TNF Therapy
Neurol 57:1885-1888, Sicotte,N.L. &Voskuhl,R.R., 2001

Primary Lymphoma of the Pituitary: An Emerging Clinical Entity
J Clin Endocrinol Metab 86:4567-4575, Giustina,A.,et al, 2001

CT and MR Imaging Features of Pyogenic Ventriculitis
AJNR 22:1510-1516, Fukui, M.,et al, 2001

Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects
NEJM 343:1608-1614, Hernandez-Dias,S.,et al, 2000

Cardiac Arrhythmias and Stroke
Stroke 31:2925-2929, Engstrom,G.,et al, 2000

Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000

Vitamin E and Beta Carotene Supplementation in High Risk for Stroke
Arch Neurol 57:1503-1509, Leppala,J.M.,et al, 2000

Recommendations for the Management of Patients with Unruptured Intracranial Aneurysms
Stroke 31:2742-2750, Bederson,J.B.,et al, 2000

Statins and the Risk of Dementia
Lancet 356:1627-1631, Jick,H.,et al, 2000

Homocysteine and Neurologic Disease
Arch Neurol 57:1422-1428, Diaz-Arrastia,R., 2000

The Association Between the Diameter of a Patent Foramen Ovale and the Risk of Embolic Cerebrovascular Events
Am J Med 109:456-462,506, Schuchlenz,H.W.,et al, 2000

Interatrial Septal Abnormalities and Stroke
Neurol 55:1172-1179, Overell,J.R.,et al, 2000

Assessment:Prevention of Post-Lumbar Puncture Headaches
Neurol 55:909-914, Evans,R.W.,et al, 2000

Warfarin-Associated Hemorrhage and Cerebral Amyloid Angiopathy
Neurol 55:947-951, Rosand,J.,et al, 2000

Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications
Stroke 31:2407-2413, De Castro,S.,et al, 2000

Handheld Cellular Telephone use and Risk of Brain Cancer
JAMA 284:3001-3007, Muscat,J.E.,et al, 2000

Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000

Phenylpropanolamine and the Risk of Hemorrhagic Stroke
NEJM 343:1826-1832,1886, Kernan,W.N.,et al, 2000

Rivastigmine (Exelon) for Alzheimer's Disease
The Medical Letter 42:93-94, , 2000

Posttraumatic Headache-A Myth?
Arch Neurol 57:1778-1780, Warner,J.S., 2000

Short-term Prognosis After Emergency Department Diagnosis of TIA
JAMA 284:2901-2906, Johnston,S.C.,et al, 2000

Stroke and Pregnancy
Stroke 31:2948-2951, Jaigobin,C. & Silver,F.L., 2000

Physical Activity and Subarachnoid Haemorrhage: A Population Based Case-Control Study
JNNP 69:768-772, Fann,J.R.,et al, 2000

A 5-Month, Randomized, Placebo-controlled Trial of Galantamine in AD
Neurol 54:2269-2276, Tariot,P.N.,et al, 2000

Galantamine in AD
Neurol 54:2261-2268, Raskind,M.A.,et al, 2000

Tonic Seizures are a Particular Risk Factor for Drowning in People with Epilepsy
BMJ 321:975-976, Besag,F.M.C., 2000



Showing articles 1650 to 1700 of 7385 << Previous Next >>